These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22001428)

  • 1. Chronic anti-phencyclidine monoclonal antibody therapy decreases phencyclidine-induced in utero fetal mortality in pregnant rats.
    Hubbard JJ; Laurenzana EM; Williams DK; Gentry WB; Owens SM
    Int Immunopharmacol; 2011 Dec; 11(12):2181-7. PubMed ID: 22001428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fate and function of therapeutic antiaddiction monoclonal antibodies across the reproductive cycle of rats.
    Hubbard JJ; Laurenzana EM; Williams DK; Gentry WB; Owens SM
    J Pharmacol Exp Ther; 2011 Feb; 336(2):414-22. PubMed ID: 20962030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single dose of monoclonal anti-phencyclidine IgG offers long-term reductions in phencyclidine behavioral effects in rats.
    Hardin JS; Wessinger WD; Wenger GR; Proksch JW; Laurenzana EM; Owens SM
    J Pharmacol Exp Ther; 2002 Jul; 302(1):119-26. PubMed ID: 12065708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-phencyclidine monoclonal antibody binding capacity is not the only determinant of effectiveness, disproving the concept that antibody capacity is easily surmounted.
    Pitas G; Laurenzana EM; Williams DK; Owens SM; Gentry WB
    Drug Metab Dispos; 2006 Jun; 34(6):906-12. PubMed ID: 16507651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering and characterization of a mouse/human chimeric anti-phencyclidine monoclonal antibody.
    Lacy HM; Gunnell MG; Laurenzana EM; Owens SM
    Int Immunopharmacol; 2008 Jan; 8(1):1-11. PubMed ID: 18068094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of adverse effects of excessive phencyclidine exposure in rats with a minimal dose of monoclonal antibody.
    Laurenzana EM; Gunnell MG; Gentry WB; Owens SM
    J Pharmacol Exp Ther; 2003 Sep; 306(3):1092-8. PubMed ID: 12829731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-phencyclidine monoclonal antibodies provide long-term reductions in brain phencyclidine concentrations during chronic phencyclidine administration in rats.
    Proksch JW; Gentry WB; Owens SM
    J Pharmacol Exp Ther; 2000 Mar; 292(3):831-7. PubMed ID: 10688594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gestational exposure to phencyclidine (PCP) in rats decreases PCP binding sites in term fetal brain.
    Ali SF; Ahmad G; Slikker W; Body SC
    Int J Dev Neurosci; 1988; 6(6):547-52. PubMed ID: 2852452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical anti-schizophrenic drugs prevent changes in cortical N-methyl-D-aspartate receptors and behavior following sub-chronic phencyclidine administration in developing rat pups.
    Anastasio NC; Johnson KM
    Pharmacol Biochem Behav; 2008 Oct; 90(4):569-77. PubMed ID: 18544461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of anti-phencyclidine and anti-(+)-methamphetamine monoclonal antibodies alone and in combination on the discrimination of phencyclidine and (+)-methamphetamine by pigeons.
    Daniels JR; Wessinger WD; Hardwick WC; Li M; Gunnell MG; Hall CJ; Owens SM; McMillan DE
    Psychopharmacology (Berl); 2006 Mar; 185(1):36-44. PubMed ID: 16479372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of locomotor sensitization induced by chronic phencyclidine administration.
    Phillips M; Wang C; Johnson KM
    J Pharmacol Exp Ther; 2001 Mar; 296(3):905-13. PubMed ID: 11181923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of gestational exposure to phencyclidine: distribution and neurochemical alterations in maternal and fetal brain.
    Ali SF; Ahmad G; Slikker W; Bondy SC
    Neurotoxicology; 1989; 10(3):383-92. PubMed ID: 2576301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal phencyclidine exposure alters hippocampal cell proliferation in offspring rats.
    Tanimura A; Liu J; Namba T; Seki T; Matsubara Y; Itoh M; Suzuki T; Arai H
    Synapse; 2009 Sep; 63(9):729-36. PubMed ID: 19425051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of acute and chronic antidepressant administration on phencyclidine (PCP) induced locomotor hyperactivity.
    Redmond AM; Harkin A; Kelly JP; Leonard BE
    Eur Neuropsychopharmacol; 1999 Jan; 9(1-2):165-70. PubMed ID: 10082243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phencyclidine during pregnancy in the rat: effects on locomotor activity in the offspring.
    Hutchings DE; Bodnarenko SR; Diaz-DeLeon R
    Pharmacol Biochem Behav; 1984 Feb; 20(2):251-4. PubMed ID: 6718452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphencyclidine monoclonal Fab fragments reverse phencyclidine-induced behavioral effects and ataxia in rats.
    Valentine JL; Mayersohn M; Wessinger WD; Arnold LW; Owens SM
    J Pharmacol Exp Ther; 1996 Aug; 278(2):709-16. PubMed ID: 8768722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metaphit, a proposed phencyclidine (PCP) antagonist, prevents PCP-induced locomotor behavior through mechanisms unrelated to specific blockade of PCP receptors.
    French ED; Jacobson AE; Rice KC
    Eur J Pharmacol; 1987 Aug; 140(3):267-74. PubMed ID: 2820762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of postnatal PCP treatment on locomotor behavior and striatal D2 receptor.
    Sircar R; Soliman KF
    Pharmacol Biochem Behav; 2003 Mar; 74(4):943-52. PubMed ID: 12667909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice.
    Gleason SD; Shannon HE
    Psychopharmacology (Berl); 1997 Jan; 129(1):79-84. PubMed ID: 9122367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of phencyclidine-induced changes in locomotor activity and patterns in rats by serotonin.
    Krebs-Thomson K; Lehmann-Masten V; Naiem S; Paulus MP; Geyer MA
    Eur J Pharmacol; 1998 Feb; 343(2-3):135-43. PubMed ID: 9570460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.